Advertisement

A pair of House Republicans promise to take a closer look at the FDA, calling for an independent advisory committee to help provide insight and point out areas of improvement at the federal watchdog agency.

Capitol Hill

A duo of House Energy & Commerce Committee Republicans announced this week that they plan to take a closer look at the FDA's life sciences initiatives, suggesting that the agency may need an advisory panel to watch its performance.

Reps. Michael Burgess (R-Texas) and Joe Pitts (R-Pa.) committed to taking a stronger hand in oversight of the FDA, particularly the way the agency handles innovative new products, drugs and biologics, Healthwatch reported.

Advertisement
Advertisement